What is TVGN's current stock price?

TVGN (Tevogen Bio Holdings Inc.) is currently trading at $8.60 with a market cap of $36.0M.

What sector is Tevogen Bio Holdings Inc. in?

Tevogen Bio Holdings Inc. (TVGN) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

TVGN Tevogen Bio Holdings Inc.

Healthcare

$8.60-10.51%ClosedMarket Cap: $36.0M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-3.40

P/S

0.00

EV/EBITDA

-2.06

DCF Value

$-1.68

FCF Yield

-29.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

241.4%

ROA

-433.9%

ROIC

5744.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-5.4M	$—
Q4 null	$0.00	$-4.7M	$—
FY null	$0.00	$-26.3M	$—
Q3 null	$0.00	$-5.7M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

D. Boral CapitalHold

2026-03-04

D. Boral CapitalBuy

2026-03-03

D. Boral CapitalBuy

2025-11-20

D. Boral CapitalBuy

2025-09-04

D. Boral CapitalBuy

2025-08-04

Trading Activity

Insider Trades

View All

Flomenberg Nealofficer: See Remarks

SellTue Mar 17

Flomenberg Nealofficer: See Remarks

SellTue Mar 17

Flomenberg Nealofficer: See Remarks

SellTue Mar 17

Saadi Ryan H.director, 10 percent owner, officer: Chief Executive Officer

SellMon Dec 22

Desai Kirtiofficer: Chief Financial Officer

SellMon Dec 15

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

0.10

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Peers

TIL